Allarity Therapeutics, Inc. (ALLR)

NASDAQ: ALLR · Real-Time Price · USD

1.160

+0.030 (2.65%)

At close: Apr 2, 2026, 4:00 PM EDT

1.140

-0.020 (-1.72%)

After-hours: Apr 2, 2026, 6:49 PM EDT

Allarity Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	14.69	19.53	0.17	2.03	19.56
Short-Term Investments	-	-	-	-	0.35
Cash & Short-Term Investments	14.69	19.53	0.17	2.03	19.91
Cash Growth	-24.81%	11666.87%	-91.82%	-89.81%	1641.47%
Other Receivables	0.87	2.19	0.82	0.79	0.84
Total Trade Receivables	0.87	2.19	0.82	0.79	0.84
Other Current Assets	2.38	0.62	0.99	2.15	0.66
Total Current Assets	17.93	22.34	1.97	4.97	21.4
Net Property, Plant & Equipment	0.33	0.31	0.02	0.03	0.09
Other Intangible Assets	-	-	9.87	9.55	28.14
Total Assets	18.26	22.65	11.86	14.54	49.63
Accounts Payable	4.28	4.18	8.42	6.25	0.7
Accrued Expenses	2.75	5.31	1.37	1.95	8.65
Short-Term Debt	-	-	-	2.64	-
Current Portion of Long-Term Debt	1.4	1.35	1.3	-	-
Current Portion of Leases	-	-	-	0.01	0.1
Other Current Liabilities	-	0	3.08	0.37	11.27
Total Current Liabilities	8.43	10.84	14.17	11.22	20.72
Long-Term Debt	-	-	-	1.08	0.98
Long-Term Leases	-	-	-	-	0.01
Other Long-Term Liabilities	-	-	0.45	0.35	9.14
Total Long-Term Liabilities	-	-	0.45	1.43	10.13
Total Liabilities	8.43	10.84	14.61	12.65	30.85
Common Stock	0	0	-	-	0
Treasury Stock	-3.19	-	-	-	-
Additional Paid-in Capital	144.23	131.13	90.37	83.16	85.24
Accumulated Other Comprehensive Income	-1.02	-0.35	-0.41	-0.72	-0.6
Retained Earnings	-130.2	-118.97	-94.45	-82.55	-66.49
Total Common Shareholders' Equity	9.83	11.81	-4.49	-0.11	18.15
Minority Interest	-	-	1.74	4.01	1.26
Shareholders' Equity	9.83	11.81	-2.75	3.89	19.42
Total Liabilities & Equity	18.26	22.65	11.86	14.54	49.63
Total Debt	1.4	1.35	1.3	3.74	1.09
Net Cash (Debt)	13.29	18.18	-1.13	-1.71	18.82
Net Cash Growth	-26.93%	-	-	-	-
Net Cash Per Share	0.92	11.31	-335.01	-3010.59	62147.88
Book Value	9.83	11.81	-4.49	-0.11	18.15
Book Value Per Share	0.68	7.35	-1327.33	-199.41	59945.18
Tangible Book Value	9.83	11.81	-14.36	-9.66	-9.98
Tangible Book Value Per Share	0.68	7.35	-4243.43	-17050.59	-32967.87

Updated Mar 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q